Attached files

file filename
EX-23.3 - Frankly Incex23-3.htm
EX-23.2 - Frankly Incex23-2.htm
EX-23.1 - Frankly Incex23-1.htm
EX-5.2 - Frankly Incex5-2.htm
EX-4.6 - Frankly Incex4-6.htm
EX-1.1 - Frankly Incex1-1.htm
S-1/A - Frankly Incforms-1a.htm

 

 

 

July 18, 2017

 

Frankly Inc.

333 Bryant Street, Suite 240

San Francisco, CA 94107

 

Dear Sirs:

 

Re:    Frankly Inc. - Public offering of Units

 

You have requested our opinion with respect to certain matters in connection with the filing by Frankly Inc., a corporation governed by the laws of British Columbia (the “ Company “), of a Registration Statement on Form S-1 dated November 14, 2016, as amended on January 11, 2017 and as further amended on February 1, 2017, April 18, 2017, May 11, 2017, May 19, 2017, May 22, 2017, June 2, 2017, June 16, 2017, June 27, 2017 and July 18, 2017 (the “Registration Statement”) with the United States Securities and Exchange Commission, covering an underwritten public offering (the “Offering”) of up to an aggregate of 2,400,000 common shares of the Company (the “Offered Shares”) and 2,400,000 common share purchase warrants (“Warrants”). Each Warrant is exercisable to purchase one additional common share (each, a “Warrant Share”).

 

In addition, up to an additional 360,000 common shares of the Company (the “Over-Allotment Shares”), common share purchase warrants (the “Over-Allotment Warrants”) or a combination thereof may be sold by the Company pursuant to the exercise of an over-allotment option granted to the underwriters. Each Over-Allotment Warrant is exercisable to purchase one additional common share (the “Over-Allotment Warrant Shares”) on the same terms as the Warrants.

 

The Company has also agreed to issue to the underwriters in the Offering warrants to purchase that number of common shares of the Company (the “Underwriter Shares”) as is equal to 8% of the aggregate number of Offered Shares, if any, sold in the Offering and common share purchase warrants (the “Underwriter Warrants”) as is equal to 8% of the aggregate number of Warrants, if any, sold in the Offering. Each Underwriter Warrant is exercisable to purchase one additional common share (each, a “Underwriter Warrant Share”) on the same terms as the Warrants.

 

In connection with this opinion, we have examined and relied upon (a) the Registration Statement and related prospectus, (b) the Company’s Notice of Articles and Articles, as currently in effect, and (c) originals or copies certified to our satisfaction of such records, documents, certificates, memoranda and other instruments as in our judgment are necessary or appropriate to enable us to render the opinion expressed below. We have assumed the genuineness and authenticity of all documents submitted to us as originals, and the conformity to originals of all documents submitted to us as copies where due execution and delivery are a prerequisite to the effectiveness thereof. As to certain factual matters, we have relied upon a certificate of officers of the Company and have not sought to independently verify such matters. Our opinion is expressed only with respect to the laws of the Province of British Columbia.

 

   
 

 

 

Page 2

 

On the basis of the foregoing, and in reliance thereon, we are of the opinion that the Offered Shares, the Warrant Shares, the Over-Allotment Shares, the Over-Allotment Warrant Shares, the Underwriter Shares and the Underwriter Warrant Shares have each been duly authorized, and upon the receipt of the consideration therefor in accordance with the terms of the underwriting agreement and the terms of the applicable warrants, the Offered Shares, Warrant Shares, Over-Allotment Shares, Over-Allotment Warrant Shares, Underwriter Shares and Underwriter Warrant Shares will be validly issued, fully paid and non-assessable common shares.

 

We hereby consent to the filing of this opinion as an exhibit to the Registration Statement and related prospectus and the reference to our firm under the caption “Legal Matters” in the Registration Statement. This opinion is expressed as of the date hereof, and we disclaim any undertaking to advise you of any subsequent changes in the facts stated or assumed herein or of any subsequent changes in applicable law.

 

Yours truly,  
   

“Fasken Martineau DuMoulin LLP”